Gabapentin Capsule
Product Images NDC 85534-0055
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 85534-0055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hawaii Repack, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structure (Gabapentin Fig 5)
Gabapentin-fig1 (Gabapentin Fig1)
Gabapentin-fig2 (Gabapentin Fig2)
Gabapentin-fig3 (Gabapentin Fig3)
This text provides a graphical representation of the proportion of responders in patients with a 50% reduction in pain score at the endpoint of controlled PHN studies. It shows varying percentages corresponding to different treatment groups such as GBP 3600, PBO, GEBP 1800, and GBP 2400. The statistical significance levels are also indicated for the observed differences in response rates.*
Gabapentin-fig4.jpg (Gabapentin Fig4)
Image Description (Label 100mg)
Image Description (Label 300mg)
Image Description (Label 400mg)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.